company background image
NEU logo

NEUCA WSE:NEU 주식 보고서

최종 가격

zł783.00

시가총액

zł3.5b

7D

0.9%

1Y

-1.8%

업데이트

22 Nov, 2024

데이터

회사 재무 +

NEUCA S.A.

WSE:NEU 주식 보고서

시가총액: zł3.5b

NEU 주식 개요

NEUCA S.A.는 폴란드에서 의약품 도매 유통업을 하고 있습니다. 자세한 내용

NEU 기본 분석
눈송이 점수
가치 평가3/6
미래 성장4/6
과거 실적4/6
재무 상태5/6
배당금4/6

보상

공정 가치 추정치보다 낮은 39.6% 에서 거래

수익은 매년 25.65% 증가할 것으로 예상됩니다.

지난 5년 동안 수입이 매년 3% 증가했습니다.

위험 분석

지난 1년 동안 주주가 희석되었습니다.


NEUCA S.A. 경쟁사

Voxel

WSE:VOX

zł1.3b

Massmedica

WSE:MSM

zł15.5m

Centrum Medyczne ENEL-MED

WSE:ENE

zł562.8m

EMC Instytut Medyczny

WSE:EMC

zł436.9m

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 NEUCA
과거 주가
현재 주가zł783.00
52주 최고치zł969.00
52주 최저치zł730.00
베타0.42
11개월 변경-5.55%
3개월 변경 사항-11.02%
1년 변경 사항-1.76%
33년 변화-2.13%
5년 변화104.44%
IPO 이후 변화1,712.50%

최근 뉴스 및 업데이트

NEUCA (WSE:NEU) Might Become A Compounding Machine

Nov 20
NEUCA (WSE:NEU) Might Become A Compounding Machine

NEUCA S.A.'s (WSE:NEU) Intrinsic Value Is Potentially 56% Above Its Share Price

Sep 19
NEUCA S.A.'s (WSE:NEU) Intrinsic Value Is Potentially 56% Above Its Share Price

Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Aug 13
Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Risks To Shareholder Returns Are Elevated At These Prices For NEUCA S.A. (WSE:NEU)

Jul 19
Risks To Shareholder Returns Are Elevated At These Prices For NEUCA S.A. (WSE:NEU)

Recent updates

NEUCA (WSE:NEU) Might Become A Compounding Machine

Nov 20
NEUCA (WSE:NEU) Might Become A Compounding Machine

NEUCA S.A.'s (WSE:NEU) Intrinsic Value Is Potentially 56% Above Its Share Price

Sep 19
NEUCA S.A.'s (WSE:NEU) Intrinsic Value Is Potentially 56% Above Its Share Price

Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Aug 13
Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Risks To Shareholder Returns Are Elevated At These Prices For NEUCA S.A. (WSE:NEU)

Jul 19
Risks To Shareholder Returns Are Elevated At These Prices For NEUCA S.A. (WSE:NEU)

NEUCA (WSE:NEU) Seems To Use Debt Quite Sensibly

Mar 08
NEUCA (WSE:NEU) Seems To Use Debt Quite Sensibly

Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Dec 29
Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Here's Why NEUCA (WSE:NEU) Can Manage Its Debt Responsibly

Dec 05
Here's Why NEUCA (WSE:NEU) Can Manage Its Debt Responsibly

NEUCA (WSE:NEU) Hasn't Managed To Accelerate Its Returns

Apr 16
NEUCA (WSE:NEU) Hasn't Managed To Accelerate Its Returns

An Intrinsic Calculation For NEUCA S.A. (WSE:NEU) Suggests It's 32% Undervalued

Jan 17
An Intrinsic Calculation For NEUCA S.A. (WSE:NEU) Suggests It's 32% Undervalued

Capital Investment Trends At NEUCA (WSE:NEU) Look Strong

Oct 25
Capital Investment Trends At NEUCA (WSE:NEU) Look Strong

Here's Why We Think NEUCA (WSE:NEU) Is Well Worth Watching

Aug 04
Here's Why We Think NEUCA (WSE:NEU) Is Well Worth Watching

Is There An Opportunity With NEUCA S.A.'s (WSE:NEU) 34% Undervaluation?

Jul 01
Is There An Opportunity With NEUCA S.A.'s (WSE:NEU) 34% Undervaluation?

Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Jun 18
Returns On Capital At NEUCA (WSE:NEU) Have Stalled

NEUCA (WSE:NEU) Is Increasing Its Dividend To zł11.50

Apr 21
NEUCA (WSE:NEU) Is Increasing Its Dividend To zł11.50

NEUCA (WSE:NEU) Is Increasing Its Dividend To zł11.50

Apr 07
NEUCA (WSE:NEU) Is Increasing Its Dividend To zł11.50

NEUCA (WSE:NEU) Knows How To Allocate Capital

Mar 15
NEUCA (WSE:NEU) Knows How To Allocate Capital

Does NEUCA (WSE:NEU) Have A Healthy Balance Sheet?

Jan 03
Does NEUCA (WSE:NEU) Have A Healthy Balance Sheet?

Is NEUCA (WSE:NEU) Using Too Much Debt?

Jun 14
Is NEUCA (WSE:NEU) Using Too Much Debt?

With EPS Growth And More, NEUCA (WSE:NEU) Is Interesting

May 19
With EPS Growth And More, NEUCA (WSE:NEU) Is Interesting

Investors Shouldn't Overlook NEUCA's (WSE:NEU) Impressive Returns On Capital

Mar 30
Investors Shouldn't Overlook NEUCA's (WSE:NEU) Impressive Returns On Capital

A Look At The Fair Value Of NEUCA S.A. (WSE:NEU)

Mar 15
A Look At The Fair Value Of NEUCA S.A. (WSE:NEU)

Did You Participate In Any Of NEUCA's (WSE:NEU) Fantastic 211% Return ?

Mar 02
Did You Participate In Any Of NEUCA's (WSE:NEU) Fantastic 211% Return ?

Is Now The Time To Put NEUCA (WSE:NEU) On Your Watchlist?

Feb 18
Is Now The Time To Put NEUCA (WSE:NEU) On Your Watchlist?

Is NEUCA S.A.'s(WSE:NEU) Recent Stock Performance Tethered To Its Strong Fundamentals?

Feb 06
Is NEUCA S.A.'s(WSE:NEU) Recent Stock Performance Tethered To Its Strong Fundamentals?

Should You Rely On NEUCA's (WSE:NEU) Earnings Growth?

Jan 26
Should You Rely On NEUCA's (WSE:NEU) Earnings Growth?

The Case For NEUCA S.A. (WSE:NEU): Could It Be A Nice Addition To Your Dividend Portfolio?

Jan 15
The Case For NEUCA S.A. (WSE:NEU): Could It Be A Nice Addition To Your Dividend Portfolio?

Is NEUCA (WSE:NEU) Using Too Much Debt?

Jan 04
Is NEUCA (WSE:NEU) Using Too Much Debt?

The Trend Of High Returns At NEUCA (WSE:NEU) Has Us Very Interested

Dec 23
The Trend Of High Returns At NEUCA (WSE:NEU) Has Us Very Interested

Is NEUCA S.A. (WSE:NEU) Trading At A 24% Discount?

Dec 13
Is NEUCA S.A. (WSE:NEU) Trading At A 24% Discount?

Could The NEUCA S.A. (WSE:NEU) Ownership Structure Tell Us Something Useful?

Dec 03
Could The NEUCA S.A. (WSE:NEU) Ownership Structure Tell Us Something Useful?

Announcing: NEUCA (WSE:NEU) Stock Increased An Energizing 122% In The Last Three Years

Nov 23
Announcing: NEUCA (WSE:NEU) Stock Increased An Energizing 122% In The Last Three Years

주주 수익률

NEUPL HealthcarePL 마켓
7D0.9%2.1%-0.2%
1Y-1.8%12.3%0.3%

수익률 대 산업: NEU 지난 1년 동안 12.3 %를 반환한 Polish Healthcare 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: NEU 지난 1년 동안 0.3 %를 반환한 Polish 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is NEU's price volatile compared to industry and market?
NEU volatility
NEU Average Weekly Movement4.1%
Healthcare Industry Average Movement4.1%
Market Average Movement4.8%
10% most volatile stocks in PL Market8.4%
10% least volatile stocks in PL Market3.0%

안정적인 주가: NEU 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: NEU 의 주간 변동성( 4% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립직원CEO웹사이트
19904,633Piotr Sucharskiwww.neuca.pl

뉴카는 폴란드에서 의약품 도매 유통을 하고 있습니다. 의약품 도매 유통, 의약품 제조, 의료 운영자, 임상 시험 및 보험 활동 부문을 통해 운영됩니다. 이 회사는 약사, 의사, 환자에게 Swiat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, Kic Kic 브랜드로 처방약, 일반의약품, 식이 보조제, 의료기기, 더모코스메틱, 위생 제품, 개인 보호 장비, 진단 및 드레싱 재료를 소유 및 생산하고 있습니다.

NEUCA S.A. 기본 사항 요약

NEUCA 의 수익과 매출은 시가총액과 어떻게 비교하나요?
NEU 기본 통계
시가총액zł3.51b
수익(TTM)zł161.38m
수익(TTM)zł12.34b

21.7x

P/E 비율

0.3x

P/S 비율

NEU 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
NEU 손익 계산서(TTM)
수익zł12.34b
수익 비용zł10.91b
총 이익zł1.43b
기타 비용zł1.27b
수익zł161.38m

최근 보고된 수익

Sep 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)36.05
총 마진11.57%
순이익 마진1.31%
부채/자본 비율40.8%

NEU 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

1.9%

현재 배당 수익률

40%

지급 비율